Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). (Q33989437)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). |
scientific article |
Statements
1 reference
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). (English)
1 reference
Pierre-Alain Clavien
1 reference
Mickael Lesurtel
1 reference
Achim Weber
1 reference
Hauke Lang
1 reference
Stefan Heinrich
1 reference
Bernhard Pestalozzi
1 reference
Frederik Berrevoet
1 reference
Stéphanie Laurent
1 reference
Jean-Robert Delpero
1 reference
Jean-Luc Raoul
1 reference
Phillippe Bachellier
1 reference
Patrick Dufour
1 reference
Markus Moehler
1 reference
Xavier Rogiers
1 reference
10 August 2011
1 reference
1 reference
11
1 reference
346
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference